Tag: global

By [email protected]_84

Launch a Global Medical Career with Manipal’s American University of Antigua, College of Medicine

Medical students can be an efficient contingency workforce, provided their lack of training is suitably addressed. Being capable and ready to respond to COVID-19 like pandemic situation needs crucial emphasis on disaster management and emergency medicine. The world is faced with the reality of the shortage of physicians and healthcare providers due to the challenges posed by the current epidemiological peak. From the larger perspective, it is about how the shortage of physicians worldwide is going to impact the global health scenario. A lack of training renders medical students non-essential to patient care; on the other hand, clinical training is essential to generate future responders against COVID-19. What should be the focus of medical institutions and aspiring medical students?

Manipal’s American University of Antigua College of Medicine (AUA) is one such renowned institute in the Caribbean that helps students from different corners of the world to fulfill their dreams of

Read More
By [email protected]_84

Global Amitriptyline Market to Surpass US$ 762.6 Million by 2027, Says Coherent Market Insights (CMI)

According to Coherent Market Insights, the global amitriptyline market is estimated to be valued at US$ 527.4 million in 2020 and is expected to exhibit a CAGR of 5.3% during the forecast period (2020-2027).

Key Trends and Analysis of the Global Amitriptyline Market:

Various research institutes are studying the effect of amitriptyline for various disease indications, which is expected to drive the growth of global amitriptyline market. For instance, in April 2016, Boston Medical Center has initiated phase 2 clinical study to compare the effectiveness of amitriptyline versus placebo (inactive medication) in treating chronic laryngitis. The study is expected to complete in October 2022.

The increasing prevalence of depression or bipolar disorders is expected to drive demand for tricyclic antidepressants such as amitriptyline, and thereby contribute to the growth of the global amitriptyline market. According to the Global Burden of Disease Collaborative Network, in 2017, the prevalence of bipolar disorder

Read More
By [email protected]_84

Pamela M. Sutton-Wallace Appointed to J2 Global Board of Directors

J2 Global, Inc. (NASDAQ: JCOM), a leading Internet information and services company, today announced the appointment to its board of directors of Pamela M. Sutton-Wallace, MPH, an experienced healthcare executive who has worked in several leading academic medical centers.

“We are delighted to have Pam join our Board of Directors,” said J2 Global Board Chairman Richard Ressler. “She is a nationally recognized leader in healthcare who will bring deep operating and strategic expertise to our Board.”

Pam brings more than 25 years of healthcare industry experience and currently serves as Senior Vice President and Regional Chief Operating Officer of New York Presbyterian. Previously, Pam was Chief Executive Officer at the University of Virginia Medical Center. Prior to that, Pam served as Senior Vice President of Hospital Operations at Duke University Hospital, where she also held leadership positions across the Duke University Health System. Pam earned a Master’s of Public Health

Read More
By [email protected]_84

China is doubling down in the global push for a coronavirus vaccine

And while the successful development of a vaccine would not preclude other countries from continuing to pursue their own research, China has placed special emphasis on being first.

As of October, four of the 10 Covid-19 vaccine candidates that have entered Phase 3 clinical trials worldwide — the last and most important step of testing before regulatory approval is sought — were developed by Chinese companies.

Two are from China National Biotec Group (CNBG), a unit of state-owned pharmaceutical giant China National Pharmaceutical Group (Sinopharm). Another candidate, CoronaVac, was developed by drugmaker Sinovac Biotech, with the remaining one jointly developed by the Chinese military-linked Beijing Institute of Biotechnology and vaccine company CanSino Biologics.

Two coronavirus vaccine candidates from the China National Biotec Group (CNBG) are now in phase 3 clinical trials.

CNBG Chairman Yang Xiaoming said last month that the progress of its vaccines was going “faster than expected.” The company has carried out Phase 3 trials in countries including the United Arab Emirates, Bahrain, Peru, Morocco, and

Read More
By [email protected]_84

WHO reports record one-day rise in global coronavirus cases amid European outbreak

By Lisa Shumaker

(Reuters) – The World Health Organization reported a record one-day increase in global coronavirus cases on Thursday, with the total rising by 338,779 in 24 hours led by a surge of infections in Europe.

Europe reported 96,996 new cases, the highest total for the region ever recorded by the WHO.

Global deaths rose by 5,514 to a total of 1.05 million.

The previous WHO record for new cases was 330,340 on Oct. 2. The agency reported a record 12,393 deaths on April 17.

As a region, Europe is now reporting more cases than India, Brazil or the United States.

India reported 78,524 new cases, followed by Brazil at 41,906 and the United States with 38,904 new infections, according to the WHO, whose data lags the daily reports by each country.

According to a Reuters analysis of more recent country data, COVID-19 infections are rising in 54 countries,

Read More
By [email protected]_84

Global Phased Array Ultrasonic Transducer Market to Surpass US$ 729.1 Million by 2027, Says Coherent Market Insights (CMI)

According to Coherent Market Insights, the global phased array ultrasonic transducer market is estimated to be valued at US$ 525.6 million in 2020 and is expected to exhibit a CAGR of 4.80 % over the forecast period (2020-2027).

Key Trends and Analysis of the Global Phased Array Ultrasonic Transducer Market:

The global phased array ultrasonic transducer market is expected to show significant growth during the forecast period, owing to key companies focusing on product launches and product approvals to strengthen their position in the phase array ultrasonic transducer market. For instance, in 2017, Alpinion Medical Systems, one of South Korea’s global medical device manufacturers, launched E-CUBE 8, a smart, reliable medical device product with developed convex and phased array transducers of PowerView technology used for high performance with high quality medical imaging and multi-purpose utility in medical imaging.

Moreover, increasing incidence of heart disease conditions such as heart attack, coronary

Read More
By [email protected]_84

Women are excluded from global coronavirus coverage, experts say

“NEVER tell a woman (professional or otherwise) that she cannot speak with authority,” she wrote later on Twitter. “NEVER tell us we aren’t educated enough, experts enough, or good enough. We have every bit as much authority to speak.”

The exchange underscored a broader concern over the lack of female voices in media coverage of and policy debates on the coronavirus pandemic.

In coverage of the coronavirus, female scientists and doctors are cited far less frequently than their male counterparts, according to multiple multicountry studies. And when women are vocal, as with other policy debates and key areas of coverage, they often face online harassment and second-guessing of their expertise, several female scientists told The Washington Post.

The consequences are far-reaching. The marginalization of female experience and expertise colors the information available to policymakers forming coronavirus responses — which means interests and issues important to women may get underprioritized.

Read More
By [email protected]_84

Global Collagen Filler Market to surpass US$ 648.1 Million by 2027, Says Coherent Market Insights (CMI)

According to Coherent Market Insights, the global collagen filler market is estimated to be valued at US$ 648.1 million in 2020 and is expected to exhibit a CAGR of 7.4 % during the forecast period (2020-2027).

Key Trends and Analysis of the Global Collagen Filler Market:

Key companies are focusing on research and development activity and technological advancement in collagen filler is expected to drive the global collagen filler market growth. For instance, in September 2020, CollPlant, an aesthetic medicine company, presented the overview of a plant-derived recombinant human collagen for anti-ageing therapies at the Science of Aging Virtual Symposium 2020 which is a symposium event for showcasing innovation in the field of aesthetic medicine.

Moreover, increasing cosmetic procedures such as face lifts, wrinkle removal, breast augmentation, and lip treatments are expected to drive the global collagen filler market growth. For instance, according to American Society of Plastic Surgeons Report

Read More
By [email protected]_84

Global Dental Air Polishing Unit Market to Surpass US$ 700.5 Million by 2027, Says Coherent Market Insights (CMI)

According to Coherent Market Insights, the global dental air polishing unit market is estimated to be valued at US$ 519.7 million in 2020 and is expected to exhibit a CAGR of 4.4% during the forecast period (2020-2027).

Key Trends and Analysis of the Global Dental Air Polishing Unit Market:

Key trends in the market include increasing prevalence of dental diseases and adoption of growth strategies such as product launches and collaboration, and others.

Market players are engaged in inorganic strategies such as acquisitions and collaborations, which is expected to boost growth of the global dental air polishing unit market over the forecast period. For instance, on August 17, 2020, NSK Ltd. collaborated with DCI Edge, a dental furniture and equipment manufacturer and integrated the NSK’s NLZ E Electric Motor system on all DCI Edge delivery systems. The integrated equipment will add an advantage for the clinicians of having efficient controlling,

Read More
By [email protected]_84

Live Covid-19 Global Updates – The New York Times

Credit…Anna Moneymaker for The New York Times

In photos and videos released by the White House, there was hardly any sign that President Trump is sick, and painting in the broadest of strokes, his doctors offered a fairly rosy portrait of his condition.

But to some outside experts who examined that portrait closely, some things seemed off.

How much, for example, should people make of the president’s fluctuating oxygen levels? And why did his doctors decide to begin treatment with a steroid drug?

Too some infectious disease experts, there were signs that Mr. Trump may be suffering a more severe case of Covid-19, the disease caused by the coronavirus, than his physicians have acknowledged.

“This is no longer aspirationally positive,” Dr. Esther Choo, a

Read More